ITBO910476A0 - -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali. - Google Patents
-formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali.Info
- Publication number
- ITBO910476A0 ITBO910476A0 IT91BO476A ITBO910476A ITBO910476A0 IT BO910476 A0 ITBO910476 A0 IT BO910476A0 IT 91BO476 A IT91BO476 A IT 91BO476A IT BO910476 A ITBO910476 A IT BO910476A IT BO910476 A0 ITBO910476 A0 IT BO910476A0
- Authority
- IT
- Italy
- Prior art keywords
- vaginal
- treatment
- pharmaceutical formulations
- formulations containing
- infections
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 title 1
- 229960003040 rifaximin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITBO910476A IT1253711B (it) | 1991-12-17 | 1991-12-17 | Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali |
US07/899,421 US5314904A (en) | 1991-12-17 | 1992-06-16 | Pharmaceutical compositions containing rifaximin for treatment of vaginal infections |
TW081105403A TW217385B (it) | 1991-12-17 | 1992-07-08 | |
CA002073601A CA2073601C (en) | 1991-12-17 | 1992-07-10 | Pharmaceutical compositions containing rifaximin for treatment of vaginal infections |
KR1019920012471A KR0149519B1 (ko) | 1991-12-17 | 1992-07-14 | 질감염 치료용 질의약 조성물과 그 제조 방법 |
MX9204132A MX9204132A (es) | 1991-12-17 | 1992-07-15 | Composiciones farmaceuticas que contienen rifaximin y procedimiento para su preparacion. |
DE69206245T DE69206245T2 (de) | 1991-12-17 | 1992-08-10 | Rifaximin enthaltendes Arzneimittel zur Behandlung von Vaginalinfektionen. |
DK92113603.2T DK0547294T3 (da) | 1991-12-17 | 1992-08-10 | Farmaceutiske præparater indeholdende rifaximin til behandling af vaginalinfektioner |
ES92113603T ES2081531T3 (es) | 1991-12-17 | 1992-08-10 | Composiciones farmaceuticas que contienen rifaximina para el tratamiento de infecciones vaginales. |
EP92113603A EP0547294B1 (en) | 1991-12-17 | 1992-08-10 | Pharmaceutical compositions containing rifaximin for treatment of vaginal infections |
AT92113603T ATE130510T1 (de) | 1991-12-17 | 1992-08-10 | Rifaximin enthaltendes arzneimittel zur behandlung von vaginalinfektionen. |
JP4266034A JP2834951B2 (ja) | 1991-12-17 | 1992-10-05 | 細菌性腟症用予防および治療剤 |
US08/181,259 US6140355A (en) | 1991-12-17 | 1994-01-13 | Pharmaceutical compositions containing rifaximin for treatment of vaginal infections |
GR950403212T GR3018205T3 (en) | 1991-12-17 | 1995-11-23 | Pharmaceutical compositions containing rifaximin for treatment of vaginal infections. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITBO910476A IT1253711B (it) | 1991-12-17 | 1991-12-17 | Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali |
Publications (3)
Publication Number | Publication Date |
---|---|
ITBO910476A0 true ITBO910476A0 (it) | 1991-12-17 |
ITBO910476A1 ITBO910476A1 (it) | 1993-06-17 |
IT1253711B IT1253711B (it) | 1995-08-23 |
Family
ID=11337881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITBO910476A IT1253711B (it) | 1991-12-17 | 1991-12-17 | Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali |
Country Status (13)
Country | Link |
---|---|
US (2) | US5314904A (it) |
EP (1) | EP0547294B1 (it) |
JP (1) | JP2834951B2 (it) |
KR (1) | KR0149519B1 (it) |
AT (1) | ATE130510T1 (it) |
CA (1) | CA2073601C (it) |
DE (1) | DE69206245T2 (it) |
DK (1) | DK0547294T3 (it) |
ES (1) | ES2081531T3 (it) |
GR (1) | GR3018205T3 (it) |
IT (1) | IT1253711B (it) |
MX (1) | MX9204132A (it) |
TW (1) | TW217385B (it) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US20030118645A1 (en) * | 1998-04-29 | 2003-06-26 | Pather S. Indiran | Pharmaceutical compositions for rectal and vaginal administration |
US20030091629A1 (en) * | 1998-03-27 | 2003-05-15 | Cima Labs Inc. | Sublingual buccal effervescent |
US6974590B2 (en) | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US6462030B1 (en) * | 1999-07-19 | 2002-10-08 | New York Blood Center, Inc. | Method for inactivating bacteria associated with bacterial vaginosis using cellulose acetate phthalate and/or hydroxypropyl methycellulose phthalate |
US6251136B1 (en) * | 1999-12-08 | 2001-06-26 | Advanced Cardiovascular Systems, Inc. | Method of layering a three-coated stent using pharmacological and polymeric agents |
RU2274442C2 (ru) | 2000-03-07 | 2006-04-20 | Раш-Презбитериан-Ст. Лук'С Медикал Сентер | Композиции и способы улавливания и инактивации патогенных микроорганизмов и сперматозоидов |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US6537538B2 (en) | 2000-12-18 | 2003-03-25 | Rush-Presbyterian-St. Luke's Medical Center | Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate |
KR100392363B1 (ko) * | 2000-12-26 | 2003-07-22 | 한국전자통신연구원 | 형광체 및 그 제조방법 |
CN1259049C (zh) * | 2001-07-06 | 2006-06-14 | 苏坎波公司 | 包含白介素-2抑制剂和抗菌剂的局部给药组合物 |
WO2004037225A2 (en) | 2002-10-25 | 2004-05-06 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
ES2385477T3 (es) * | 2002-11-05 | 2012-07-25 | Fadim S.R.L. | Liberación continua y controlada de rifaximina |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
BRPI0411429A (pt) * | 2003-06-13 | 2006-07-25 | Idh Holding Aps | tratamento de sintomas associados com vaginose bacteriana |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US20060140990A1 (en) * | 2003-09-19 | 2006-06-29 | Drugtech Corporation | Composition for topical treatment of mixed vaginal infections |
BRPI0414500A (pt) * | 2003-09-19 | 2006-11-07 | Drugtech Corp | formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais |
KR101184138B1 (ko) * | 2003-12-31 | 2012-09-19 | 시마 랩스 인크. | 일반적인 선형 발포성 경구 펜타닐 투약 제형 및 투여 방법 |
US7858121B2 (en) * | 2003-12-31 | 2010-12-28 | Cima Labs, Inc. | Effervescent oral fentanyl dosage form and methods of administering fentanyl |
JP5244318B2 (ja) * | 2003-12-31 | 2013-07-24 | シーマ・ラブス、インコーポレイテッド | 発泡性経口アヘン薬投薬形態およびアヘン薬の投与方法 |
US7125963B2 (en) * | 2004-03-03 | 2006-10-24 | En N Tech Inc | Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions |
US8003118B2 (en) * | 2005-03-02 | 2011-08-23 | Kodsi Robert E | Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis |
US20060210483A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections |
US20060210492A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Use of rifaximin for treatment and prevention of periodontal conditions |
DK1698630T3 (da) | 2005-03-03 | 2014-12-08 | Alfa Wassermann Spa | Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater |
ITBO20050123A1 (it) * | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
AU2006244260A1 (en) * | 2005-05-09 | 2006-11-16 | Drugtech Corporation | Modified-release pharmaceutical compositions |
WO2007054818A2 (en) * | 2005-05-09 | 2007-05-18 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
EA200870153A1 (ru) * | 2006-01-05 | 2008-12-30 | Драгтек Корпорейшн | Композиция и способ ее использования |
CA2635994A1 (en) * | 2006-01-05 | 2007-07-12 | Drugtech Corporation | Drug delivery system for bioadhesion to a vulvovaginal surface |
ITMI20061692A1 (it) | 2006-09-05 | 2008-03-06 | Alfa Wassermann Spa | Uso di polioli per ottenere forme polimorfe stabili di rifaximina |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US20080161337A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Chronic Prostatitis |
US20080159987A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Restless Legs Syndrome |
US20080299182A1 (en) * | 2007-03-01 | 2008-12-04 | Shuyuan Zhang | Methods and formulations for topical gene therapy |
AU2016203925B2 (en) * | 2007-07-06 | 2016-10-20 | Lupin Limited | Pharmaceutical compositions of rifaximin |
SI2011486T1 (sl) * | 2007-07-06 | 2012-10-30 | Lupin Ltd | Farmacevtski sestavki rifaksimina |
WO2009008005A1 (en) * | 2007-07-06 | 2009-01-15 | Lupin Limited | Pharmaceutical compositions of rifaximin |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
CA2712120A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
KR20110071096A (ko) | 2008-09-26 | 2011-06-28 | 아스카 세이야쿠 가부시키가이샤 | 기능성 소화관 장해의 예방 및/또는 치료제 |
WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011064631A1 (en) | 2009-10-02 | 2011-06-03 | Foamix Ltd. | Surfactant-free, water-free, foamable compositions and breakable foams and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
MX346660B (es) * | 2009-10-27 | 2017-03-28 | Lupin Ltd | Dispersion solida de rifaximina. |
US20130202654A1 (en) | 2009-11-23 | 2013-08-08 | Cipla Limited | Topical Foam Composition |
MX2012005883A (es) * | 2009-11-23 | 2012-10-09 | Cipla Ltd | Composicion topica en espuma. |
US7888062B1 (en) | 2010-02-01 | 2011-02-15 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US8445226B2 (en) | 2010-02-01 | 2013-05-21 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
WO2012076832A1 (en) | 2010-12-09 | 2012-06-14 | Cipla Limited | Suppositories comprising rifaximin |
ITBO20110461A1 (it) * | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
CN102512358B (zh) * | 2011-12-16 | 2013-04-10 | 南京农业大学 | 家畜用利福昔明阴道栓剂及其制备方法 |
EA201591267A1 (ru) | 2013-03-15 | 2016-03-31 | Альфа Вассерманн С.П.А. | Рифаксимин для применения в лечении вагинальных инфекций |
WO2014140995A2 (en) | 2013-03-15 | 2014-09-18 | Alfa Wassermann S.P.A. | Method for diagnosing vaginal infections |
ES2810010T3 (es) | 2014-05-12 | 2021-03-08 | Alfasigma Spa | Preparación y uso de la forma cristalina tau de rifaximina solvatada con DEGME |
JP6487534B2 (ja) | 2014-09-05 | 2019-03-20 | シンビオミックス セラピューティクス、エルエルシー | 細菌性膣炎の治療に使用するためのセクニダゾール |
WO2016135219A1 (en) * | 2015-02-26 | 2016-09-01 | Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol | Topical composition for the treatment of mucosal lesions |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US20190008784A1 (en) * | 2017-07-07 | 2019-01-10 | Symbiomix Therapeutics, Llc | Novel secnidazole soft gelatin capsule formulations and uses thereof |
WO2019073321A1 (en) * | 2017-10-10 | 2019-04-18 | Zenvision Pharma Llp | EFFERVESCENT COMPOSITIONS COMPRISING RIFAXIMINE |
WO2022090490A1 (en) * | 2020-10-29 | 2022-05-05 | Bausch Health Ireland Limited | Rifaximin liquid formulations for use in the treatment of sickle cell disease |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI812936L (fi) * | 1980-09-25 | 1982-03-26 | Ciba Geigy Ag | Nya 2-aminoimidazoler foerfaranden foer deras framstaellning dessa foereningar innehaollande farmaceutiska preparat och deras anvaendning |
ZA816635B (en) * | 1980-09-25 | 1982-09-29 | Ciba Geigy | Novel 2-aminoimidazoles |
IT1190445B (it) * | 1985-11-08 | 1988-02-16 | Fatro Spa | Composizioni veterinarie a base di agenti antimicrobici e loro impiego |
DE3815221C2 (de) * | 1988-05-04 | 1995-06-29 | Gradinger F Hermes Pharma | Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen |
ATE109978T1 (de) * | 1989-03-31 | 1994-09-15 | Lepetit Spa | Verwendung von purpuromycin zur behandlung von vaginalinfektionen. |
GB8908250D0 (en) * | 1989-04-12 | 1989-05-24 | Fisons Plc | Formulations |
GB9001019D0 (en) * | 1990-01-17 | 1990-03-14 | Euro Celtique Sa | Pharmaceutical aerosol |
-
1991
- 1991-12-17 IT ITBO910476A patent/IT1253711B/it active IP Right Grant
-
1992
- 1992-06-16 US US07/899,421 patent/US5314904A/en not_active Expired - Lifetime
- 1992-07-08 TW TW081105403A patent/TW217385B/zh not_active IP Right Cessation
- 1992-07-10 CA CA002073601A patent/CA2073601C/en not_active Expired - Lifetime
- 1992-07-14 KR KR1019920012471A patent/KR0149519B1/ko not_active IP Right Cessation
- 1992-07-15 MX MX9204132A patent/MX9204132A/es unknown
- 1992-08-10 AT AT92113603T patent/ATE130510T1/de active
- 1992-08-10 DK DK92113603.2T patent/DK0547294T3/da active
- 1992-08-10 DE DE69206245T patent/DE69206245T2/de not_active Expired - Lifetime
- 1992-08-10 ES ES92113603T patent/ES2081531T3/es not_active Expired - Lifetime
- 1992-08-10 EP EP92113603A patent/EP0547294B1/en not_active Expired - Lifetime
- 1992-10-05 JP JP4266034A patent/JP2834951B2/ja not_active Expired - Lifetime
-
1994
- 1994-01-13 US US08/181,259 patent/US6140355A/en not_active Expired - Lifetime
-
1995
- 1995-11-23 GR GR950403212T patent/GR3018205T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2073601A1 (en) | 1993-06-18 |
DE69206245T2 (de) | 1996-05-02 |
KR0149519B1 (ko) | 1998-10-15 |
DE69206245D1 (de) | 1996-01-04 |
GR3018205T3 (en) | 1996-02-29 |
TW217385B (it) | 1993-12-11 |
MX9204132A (es) | 1993-08-01 |
DK0547294T3 (da) | 1995-12-18 |
KR930012015A (ko) | 1993-07-20 |
ATE130510T1 (de) | 1995-12-15 |
ES2081531T3 (es) | 1996-03-16 |
JPH05255085A (ja) | 1993-10-05 |
US6140355A (en) | 2000-10-31 |
CA2073601C (en) | 1996-07-09 |
IT1253711B (it) | 1995-08-23 |
US5314904A (en) | 1994-05-24 |
EP0547294A1 (en) | 1993-06-23 |
ITBO910476A1 (it) | 1993-06-17 |
JP2834951B2 (ja) | 1998-12-14 |
EP0547294B1 (en) | 1995-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITBO910476A0 (it) | -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali. | |
ITMI920528A0 (it) | 14-beta idrossi-10-de acetil-baccatina iii, suoi derivati, loro preparazione ed impiego terapeutico | |
ITRM930236A0 (it) | Derivati di indolo; procedimenti per la loro preparazione e loro impiego in medicina. | |
MX9202839A (es) | 4-aminoquinolinas y composiciones farmaceuticas de las mismas. | |
MX9204301A (es) | Acilmercaptoalcanoildipeptidos, metodos de preparacion y su uso terapeutico. | |
IT1271462B (it) | Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche. | |
CA2105487A1 (en) | Antiviral nucleoside combination | |
FI934914A (fi) | Farmaceutiska formuleringar | |
ITRM920412A1 (it) | Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico. | |
ITMI911096A0 (it) | Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus | |
ITMI922779A1 (it) | Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche | |
ITMI912509A0 (it) | Uso della nimesulide nel trattamento della cataratta | |
ITMI911470A1 (it) | N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico | |
IT1291340B1 (it) | Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale | |
MX9200532A (es) | Agente farmaceuticos. | |
ITMI912261A1 (it) | Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego | |
IT8319600A0 (it) | Composizioni farmaceutiche e loro uso nel trattamento del glaucoma. | |
IT9019565A0 (it) | Agenti addensanti,loro preparazione ed uso | |
BR9106372A (pt) | Derivados 1,5-benzotiazepinona,suas preparacoes e uso farmaceutico | |
IT9048026A0 (it) | Preparato farmaceutico e/o cosmetico. | |
EP0449427A3 (en) | Use of an antihistamine in the treatment of alcohol intoxication | |
EP0462621A3 (en) | Use of particular compounds for manufacture of pharmaceutical formulations for treatment against various parasites, mycoplasmas, other indications and other infections | |
ITMI911930A1 (it) | Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico. | |
ITMI912264A1 (it) | Composizioni utili nella terapia delle affezioni del sistema immunitario e delle anemie | |
ZA902254B (en) | Use of purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |